John Darren Campbell

1 Patent

• US122960022025

  Immunogenic Composition Against Severe Acute Respiratory Syndrome Coronavirus 2 (sars-cov-2)

  DYNAVAX TECHNOLOGIES CORPORATION

  0 cites